BDNF and Alzheimer disease: From a clinical point of view, there is a need to find an AD biomarker that is sensitive, for the purpose of diagnosis in the early stages of the disease, before clinical symptoms appear, but which is also rapid and non-invasive, which is why BDNF has attracted the attention of researchers [3].